Streetbeat News

Analyst Ratings

ICLR

Mizuho analyst Ann Hynes maintains a Buy rating on Icon (NASDAQ:ICLR) and raises the price target from $250 to $274.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:32 am

ICE

Raymond James analyst Patrick O'Shaughnessy has maintained a 'Strong Buy' rating on Intercontinental Exchange (NYSE:ICE) and raised the price target from $127 to $130.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 11:31 am

AFRM

Mizuho has raised the price target for Affirm Holdings from $17 to $20, while maintaining the Buy rating. This has resulted in a rise in Affirm's stock trading.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:31 am

ENV

Raymond James analyst Patrick O'Shaughnessy has maintained an Outperform rating on Envestnet (NYSE:ENV) and raised the price target from $73 to $74.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 11:29 am

ARES

Wells Fargo analyst Timothy O'Shea has maintained an Equal-Weight rating on Ares Management (NYSE:ARES) and raised the price target from $93 to $97.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:29 am

UHS

Mizuho analyst Ann Hynes maintains a 'Buy' rating on Universal Health Services (NYSE:UHS) and raises the price target from $150 to $170.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:28 am

BX

Wells Fargo analyst Timothy O'Shea has maintained an Overweight rating on Blackstone (NYSE:BX) and raised the price target from $101 to $104.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:27 am

XPO

Benchmark analyst Christopher Kuhn maintains a 'Buy' rating on XPO Logistics (NYSE:XPO) and raises the price target from $53 to $65.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:26 am

THC

Mizuho analyst Ann Hynes maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $81 to $94.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:24 am

HCA

Mizuho analyst Ann Hynes has maintained a 'Buy' rating on HCA Healthcare (NYSE:HCA) and raised the price target from $305 to $325.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 11:22 am